CELLDEX
Live / Allowed — Fifth extension granted (statement of use) (as of 26 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Apr 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97887331
- Mark type
- Word mark
- Filed
- 13 Apr 2023
- Published for opposition
- 13 Feb 2024
- Attorney of record
- Matthew Hintz, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer
Owner
- CELLDEX THERAPEUTICS, INC., Hampton, NJ, US
- CELLDEX, Hampton, NJ, US
Prior registrations
Prosecution history
- 27 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Sept 2026 — SOU EXTENSION 5 GRANTED
- 17 Sept 2026 — SOU EXTENSION 5 FILED
- 17 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Apr 2026 — SOU EXTENSION 4 GRANTED
- 03 Apr 2026 — SOU EXTENSION 4 FILED
- 03 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Jan 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Dec 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2025 — SOU EXTENSION 3 GRANTED
- 04 Sept 2025 — SOU EXTENSION 3 FILED
- 04 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jul 2025 — AMENDMENT AFTER NOA NOT ENTERED